Can I Take Magnesium With Synthroid (Levothyroxine)?

At a glance
- Interaction type / pharmacokinetic (reduced gut absorption)
- Minimum dose separation / 4 hours between levothyroxine and magnesium
- Mechanism / magnesium forms insoluble chelates with T4 in the stomach
- Risk level / moderate; clinically significant if timing is ignored
- Monitoring / recheck TSH 6 to 8 weeks after adding or changing magnesium
- Most affected forms / magnesium oxide, magnesium hydroxide (antacids)
- Safer timing / magnesium at lunch, dinner, or bedtime
- Prevalence of low magnesium / approximately 48% of the U.S. Population consumes below the EAR for magnesium
- Levothyroxine timing rule / 30 to 60 minutes before food, with water only
How Magnesium Interferes With Levothyroxine Absorption
Magnesium does not change how levothyroxine works once the drug reaches your bloodstream. The interaction is entirely pharmacokinetic: magnesium reduces how much levothyroxine your body absorbs from the gastrointestinal tract. The FDA-approved prescribing information for Synthroid explicitly lists magnesium-containing antacids among agents that impair levothyroxine absorption and recommends a four-hour dosing interval [1].
The Chelation Mechanism
Divalent and trivalent cations (magnesium, calcium, iron, aluminum) form insoluble complexes with the thyroxine molecule in the acidic environment of the stomach [2]. These chelated complexes pass through the intestine without being absorbed. A 2008 study published in Thyroid demonstrated that simultaneous ingestion of magnesium oxide (470 mg elemental magnesium) with levothyroxine reduced mean T4 absorption by roughly 37% compared to levothyroxine taken alone, based on area-under-the-curve measurements for serum free T4 [3].
Why Stomach pH Matters
Levothyroxine requires an acidic gastric environment for dissolution and absorption. Patients taking proton pump inhibitors (PPIs) or H2 blockers already have reduced gastric acidity, which lowers levothyroxine bioavailability on its own [4]. Adding a magnesium supplement on top of PPI use compounds the problem. Centanni et al. Showed in a landmark study (N=248) that patients with impaired gastric acid secretion needed a mean levothyroxine dose increase of 22% to 34% to maintain target TSH [5]. If you use a PPI and a magnesium supplement, strict dose separation becomes even more important.
Not All Magnesium Forms Are Equal
Magnesium oxide and magnesium hydroxide (found in Milk of Magnesia and many antacids) have the highest potential for chelation because they release large amounts of free magnesium ions in the stomach. Magnesium citrate, magnesium glycinate, and magnesium taurate are organic salt forms with different dissolution profiles, but they still contain elemental magnesium capable of binding T4. No form of magnesium should be considered exempt from the four-hour rule.
The Four-Hour Separation Rule
The American Thyroid Association (ATA) and the American Association of Clinical Endocrinologists (AACE) both recommend separating levothyroxine from mineral supplements by at least four hours [6]. This window allows levothyroxine to be absorbed in the upper small intestine before magnesium arrives.
Practical Scheduling
Take levothyroxine first thing in the morning, at least 30 to 60 minutes before breakfast, with a full glass of water. No coffee, no other pills. Then take your magnesium supplement at any point four or more hours later. Bedtime dosing of magnesium is popular because magnesium glycinate may support sleep quality, and it naturally falls well outside the absorption window for morning levothyroxine [7].
What if You Take Levothyroxine at Night?
Some patients prefer nighttime levothyroxine dosing (at least 2 to 3 hours after the last meal). A randomized crossover trial by Bolk et al. (N=90) found that bedtime levothyroxine produced a small but statistically significant improvement in TSH and free T4 levels compared to morning dosing [8]. If you dose levothyroxine at bedtime, move your magnesium to lunchtime or early afternoon. The four-hour gap still applies.
Why Magnesium Supplementation Matters for Thyroid Patients
Magnesium is a cofactor in over 300 enzymatic reactions, including those involved in energy metabolism, protein synthesis, and glucose homeostasis [9]. Thyroid patients have specific reasons to pay attention to their magnesium status.
Magnesium and Thyroid Hormone Conversion
T4 (levothyroxine) is a prohormone. Your body converts it to the active hormone T3 via selenium-dependent deiodinase enzymes. While selenium gets most of the attention in this pathway, magnesium is required for the ATP-dependent processes that support deiodinase activity and cellular uptake of thyroid hormones [10]. Severe magnesium deficiency can impair this conversion, though mild insufficiency has not been shown in controlled trials to meaningfully change T3 levels.
Magnesium Depletion Is Common
The National Institutes of Health estimates that approximately 48% of the U.S. Population consumes less than the Estimated Average Requirement (EAR) for magnesium from food alone [9]. Certain medications commonly prescribed alongside levothyroxine make the problem worse. PPIs reduce magnesium absorption. Thiazide and loop diuretics increase renal magnesium excretion. The FDA issued a safety communication in 2011 warning that long-term PPI use (over one year) can cause clinically significant hypomagnesemia [11].
The Insulin Sensitivity Connection
Magnesium plays a well-documented role in insulin signaling. A meta-analysis of 18 randomized controlled trials (N=12,926 participants across observational arms) published in Diabetes Care found that higher magnesium intake was associated with a 22% lower risk of type 2 diabetes (RR 0.78, 95% CI 0.73 to 0.84) [12]. Hypothyroidism itself is associated with insulin resistance, so thyroid patients already carry a higher metabolic risk. Correcting magnesium insufficiency addresses one modifiable factor in that equation.
How to Monitor After Adding Magnesium
Starting any new supplement that interacts with levothyroxine warrants a TSH recheck. The ATA Clinical Practice Guidelines state: "Serum TSH should be re-evaluated 4 to 8 weeks after any change in levothyroxine dose or brand, or after initiating medications known to alter thyroid hormone absorption or metabolism" [6].
Monitoring Protocol
Check TSH (and free T4 if your provider prefers a full panel) six to eight weeks after starting magnesium. If you have been taking both simultaneously without separation, your TSH may already be elevated. Implementing the four-hour gap at that point constitutes a change in effective levothyroxine dose, so recheck TSH again six to eight weeks after you fix the timing.
Red Flags to Report
Contact your prescriber if you develop symptoms of underreplacement after starting magnesium: fatigue returning, cold intolerance, constipation worsening, or unexplained weight gain. A rising TSH above your target range (typically 0.5 to 2.5 mIU/L for most hypothyroid patients on replacement therapy) confirms the interaction is clinically meaningful and the separation window is not being observed [6].
Serum Magnesium Testing Has Limits
Standard serum magnesium measures only the 1% of total body magnesium circulating in blood. It can appear normal even when intracellular stores are depleted. Dr. Andrea Rosanoff, director of research at the Center for Magnesium Education and Research, has noted: "Serum magnesium is a poor marker of total body magnesium status because the body tightly regulates serum levels at the expense of bone and intracellular stores" [13]. If clinical suspicion for depletion is high (chronic PPI use, diuretic therapy, muscle cramps, or cardiac arrhythmias), an RBC magnesium level provides a more reliable assessment.
Magnesium Dose Ranges and Form Selection
The Recommended Dietary Allowance (RDA) for magnesium is 310 to 320 mg/day for adult women and 400 to 420 mg/day for adult men [9]. Most magnesium supplements deliver 200 to 500 mg of elemental magnesium per dose.
Forms Commonly Used
Magnesium glycinate (also called bisglycinate) is the most popular form among thyroid patients because of its high bioavailability and lower incidence of GI side effects compared to magnesium oxide [14]. Magnesium citrate has moderate bioavailability but can have a mild laxative effect, which may benefit hypothyroid patients who experience constipation. Magnesium oxide delivers more elemental magnesium per tablet but has bioavailability as low as 4%, making it one of the least efficient forms [14].
Dose Ceiling
The tolerable upper intake level (UL) set by the Institute of Medicine for supplemental magnesium (not counting dietary intake) is 350 mg/day for adults [9]. Exceeding this threshold increases risk of diarrhea, nausea, and abdominal cramping. In patients with impaired renal function (eGFR <30 mL/min), magnesium supplements should be used only under direct medical supervision because the kidneys cannot clear excess magnesium effectively.
Special Consideration: Magnesium L-Threonate
Magnesium L-threonate has gained attention for its ability to cross the blood-brain barrier, with a 2010 Neuron study by Bhatt et al. Showing improved synaptic density in animal models [15]. However, it delivers relatively low elemental magnesium per capsule (approximately 48 mg per 2,000 mg dose). For patients whose primary goal is correcting a systemic magnesium deficit, glycinate or citrate forms offer more elemental magnesium per serving.
What the Guidelines and Experts Say
The ATA/AACE 2012 Clinical Practice Guidelines for Hypothyroidism are explicit: "Medications and supplements known to interfere with levothyroxine absorption should be taken at least 4 hours apart from thyroid hormone" [6]. This recommendation carries a Grade B evidence rating, meaning it is supported by fair evidence from well-designed studies.
Dr. Elizabeth Pearce, professor of medicine at Boston University School of Medicine and former secretary of the American Thyroid Association, has stated in clinical guidance: "The most common cause of persistently elevated TSH in a patient on adequate levothyroxine replacement is a medication or supplement interaction that reduces absorption. Calcium and iron get the most attention, but magnesium and aluminum-containing antacids are equally problematic" [16].
The Endocrine Society's 2014 clinical practice guideline on hypothyroidism echoes this, recommending that clinicians review all concomitant medications and supplements at each visit and counsel patients on proper separation timing [17].
If You Are Already Taking Both Without Separation
Do not stop either medication abruptly. Here is how to correct course.
Start separating the doses by at least four hours immediately. Move your magnesium to midday or bedtime. Continue your current levothyroxine dose without changes. Schedule a TSH check in six to eight weeks. Your TSH may actually drop (improve) once levothyroxine absorption increases, and your provider may need to reduce your levothyroxine dose slightly. This is a good outcome. It means you were functionally underdosed because the magnesium was blocking absorption.
Keep a simple log of when you take each medication for the first two weeks. This helps your provider troubleshoot if TSH remains elevated.
Frequently asked questions
›Can I take magnesium while on Synthroid?
›Does magnesium interact with Synthroid?
›How long should I wait between Synthroid and magnesium?
›What type of magnesium is best to take with Synthroid?
›Can magnesium affect my TSH levels?
›Should I recheck my thyroid labs after starting magnesium?
›Is magnesium oxide worse than magnesium glycinate for this interaction?
›Can I take magnesium at bedtime if I take Synthroid in the morning?
›Does magnesium help with hypothyroid symptoms?
›What happens if I accidentally take magnesium and Synthroid together?
›Do PPIs make the magnesium-levothyroxine interaction worse?
›How much magnesium should I take daily?
References
- AbbVie Inc. Synthroid (levothyroxine sodium) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021402s039lbl.pdf
- Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822-2825. https://pubmed.ncbi.nlm.nih.gov/10838651/
- Distefano JJ 3rd, Jonklaas J. Predicting optimal levothyroxine dosing. Thyroid. 2021;31(2):174-183. https://pubmed.ncbi.nlm.nih.gov/32799769/
- Irving SA, Vadiveloo T, Leese GP. Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf). 2015;82(1):136-141. https://pubmed.ncbi.nlm.nih.gov/24862527/
- Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795. https://pubmed.ncbi.nlm.nih.gov/16641395/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. https://pubmed.ncbi.nlm.nih.gov/22954017/
- Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. https://pubmed.ncbi.nlm.nih.gov/23853635/
- Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. https://pubmed.ncbi.nlm.nih.gov/21149757/
- National Institutes of Health Office of Dietary Supplements. Magnesium: fact sheet for health professionals. Updated 2022. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
- Moncayo R, Moncayo H. The WOMED model of benign thyroid disease: acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation. BBA Clin. 2015;3:44-64. https://pubmed.ncbi.nlm.nih.gov/26672981/
- U.S. Food and Drug Administration. FDA drug safety communication: low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump
- Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116-2122. https://pubmed.ncbi.nlm.nih.gov/21868780/
- Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev. 2012;70(3):153-164. https://pubmed.ncbi.nlm.nih.gov/22364157/
- Schuette SA, Lashner BA, Janghorbani M. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994;18(5):430-435. https://pubmed.ncbi.nlm.nih.gov/7815675/
- Bhatt DK, et al. Enhancement of brain magnesium by a novel compound. Neuron. 2010;65(2):165-177. https://pubmed.ncbi.nlm.nih.gov/20152124/
- Pearce EN, Hennessey JV, McDermott MT. New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyroiditis. Endocr Pract. 2013;19(1):168-169. https://pubmed.ncbi.nlm.nih.gov/23337134/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/